Paris, Frankreich, AIDS-Aktivisten, Protest gegen Gilead Pharmaceuticals, um die Arzneimittelpreise zu senken, vor Gilead France Büros, HIV-Schwulen-Gemeinschaft, Sofosbuvir
2832 x 4256 px | 24 x 36 cm | 9,4 x 14,2 inches | 300dpi
Aufnahmedatum:
1. April 2016
Ort:
Boulogne-Billancourt, France
Weitere Informationen:
Dieses Bild kann kleinere Mängel aufweisen, da es sich um ein historisches Bild oder ein Reportagebild handel
AIDS Activists, Act UP protest against Gilead Pharmaceuticals, to lower drug prices, 1/4/16, front of Gilead France offices, Holding Liver. Global Action Against Pharma Greed: Act Up-Paris targets Gilead France and calls for unrestricted access to hepatitis C medications In France, Act Up-Paris’ activists protest today against Gilead’s greed. The prices of its hepatitis C medications (Harvoni and Sovaldi) are indeed so high that they hamper unrestricted access for all people living with hep C. After the price negotiations between Gilead and the French authorities, the relatively lower prices of Gilead’s medications in France, which were only justified by the extent of the epidemic, were balanced by a restriction of their dispensation to the people with the most severe cases, since the reduction of the financial burden on social health insurance was not significant enough to afford unrestricted access. Act Up-Paris denies the relevance of these shortsighted arguments. As time goes by, more and more activists are requiring unrestricted access to hep C treatments, so as to end the epidemic. Today, we aim to foster this move. Our demands: We demand that Gilead reduces the price of its hepatitis C medications down to the fair cost of production. This permits unrestricted access to the treatments and a reallocation of the expenses of the social health insurance on other major issues regarding public health. We demand that the French Government uses the possibilities offered by the French intellectual property laws and introduces compulsory licences for these drugs and for other medications whose prices are unfair.
